Optimizing Tissue Sampling for the Diagnosis, Subtyping, and Molecular Analysis of Lung Cancer

Lung cancer has entered the era of personalized therapy with histologic subclassification and the presence of molecular biomarkers becoming increasingly important in therapeutic algorithms. At the same time, biopsy specimens are becoming increasingly smaller as diagnostic algorithms seek to establis...

Descripción completa

Detalles Bibliográficos
Autores principales: Ofiara, Linda Marie, Navasakulpong, Asma, Beaudoin, Stephane, Gonzalez, Anne Valerie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170137/
https://www.ncbi.nlm.nih.gov/pubmed/25295226
http://dx.doi.org/10.3389/fonc.2014.00253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170137/
https://www.ncbi.nlm.nih.gov/pubmed/25295226
http://dx.doi.org/10.3389/fonc.2014.00253

Ejemplares similares